Jin Feng, Fu Yan-Jun, Zhang Yang, Yan Jing-Ling, Zhou Kui-Chen, Liu Hong-Wei
Department of Surgery.
Department of Laboratory.
Medicine (Baltimore). 2020 May;99(20):e20254. doi: 10.1097/MD.0000000000020254.
This study will be designed to appraise the effects of intraoperative pressure ulcer preventive nursing (IPUPN) on inflammatory markers (IMs) in patients with high-risk pressure ulcers (HRPU) based on high quality randomized controlled trials (RCTs).
In this study, we will perform a rigorous literature search from the following electronic databases: Cochrane Library, MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature, Allied and Complementary Medicine Database, and Chinese Biomedical Literature Database. All electronic databases will be retrieved from their initial time to March 1, 2020 without limitations of language and publication status. We will only consider high quality RCTs that explored the effects of IPUPN on IMs in patients with HRPU. Two investigators will identify relevant trials, extract data, and appraise risk of bias in each eligible trial. Data will be pooled by either a fixed-effects model or a random-effects model according to the results of heterogeneity identification. The primary outcomes include IMs, and incidence of new pressure ulcers. The secondary outcomes are time to ulcer development, quality of life, length of hospital stay, and adverse events. Statistical analysis will be undertaken using RevMan 5.3 software.
This study will summarize high quality clinical evidence of RCTs to evaluate the effects of IPUPN on IMs in patients with HRPU.
The expected findings may provide helpful evidence to determine whether IPUPN is an effective intervention on IMs in patients with HRPU.
INPLASY202040029.
本研究旨在基于高质量随机对照试验(RCT)评估术中压疮预防护理(IPUPN)对高危压疮(HRPU)患者炎症标志物(IMs)的影响。
在本研究中,我们将从以下电子数据库进行严格的文献检索:Cochrane图书馆、医学文献数据库(MEDLINE)、荷兰医学文摘数据库(Embase)、护理学与健康照护领域累积索引数据库(CINAHL)、补充与替代医学数据库(AMED)以及中国生物医学文献数据库。所有电子数据库将从其创建之初检索至2020年3月1日,不受语言和出版状态限制。我们将仅纳入探索IPUPN对HRPU患者IMs影响的高质量RCT。两名研究人员将识别相关试验、提取数据并评估每个符合条件试验的偏倚风险。根据异质性识别结果,数据将采用固定效应模型或随机效应模型进行合并。主要结局包括IMs和新压疮的发生率。次要结局为溃疡发生时间、生活质量、住院时间和不良事件。将使用RevMan 5.3软件进行统计分析。
本研究将总结RCT的高质量临床证据,以评估IPUPN对HRPU患者IMs的影响。
预期结果可能为确定IPUPN是否为HRPU患者IMs的有效干预措施提供有用证据。
国际系统评价注册平台(INPLASY)注册号:INPLASY202040029。